| Biogen Switzerland AG - Tysabri 300 mg, Konzentrat zur Herstellung einer Infusionslösung |
| 57273 | | 01 | | Tysabri 300 mg | | Konzentrat zur Herstellung einer Infusionslösung | | L04AG03 | | | | 03.05.2007 | | |
|
| Composition |
| natalizumabum 300 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 15 ml corresp. natrium 52 mg. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Natalizumab | 300mg / 15ml |
| | BAG: Active Agent | Dose |
|---|
| Natalizumab | 300 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Heptahydrate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 1548.10 | 1700.05 | B | SL | Yes |
|
